Biogen Stock Slumps On Report of Death in Alzheimer's Drug Trial
Science.org reported Sunday that a woman participating in the joint Bigoen-Eisai Clarity AD trial of an experimental Alzheimer's treatment has died of a brain hemorrhage. Biogen (B…
More from Mississippi Business
Mississippi Works
Mississippi's Pro-Business Tax Climate Strengthens Your Bottom Line
Mississippi Business
•
Aug 28, 2026
Mississippi Works
Mississippi's Reshoring Moment: Leveraging Local Strengths for Global Competitiveness
Mississippi Business
•
Jul 8, 2026
Mississippi Works
Median Household Income Continues Upward Trend
Mississippi Business
•
Apr 21, 2026
Sun Herald Business
Detroit Auto Show rebrands, releases schedule for January 2025 return
Mississippi Business
•
Jul 31, 2024
Sun Herald Business
Justi-cation? There is a new viral travel word going around
Mississippi Business
•
Jul 31, 2024
Sun Herald Business
Analysts update Southwest Airlines stock price target on revenue plan
Mississippi Business
•
Jul 31, 2024
Sun Herald Business
New Ford tech pushes the limits of driver privacy and surveillance
Mississippi Business
•
Jul 31, 2024